标题
Intravitreal anti-VEGF agents and cardiovascular risk
作者
关键词
-
出版物
Internal and Emergency Medicine
Volume 15, Issue 2, Pages 199-210
出版商
Springer Science and Business Media LLC
发表日期
2019-12-17
DOI
10.1007/s11739-019-02253-7
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Association of Intravitreal Anti–Vascular Endothelial Growth Factor Therapy With Risk of Stroke, Myocardial Infarction, and Death in Patients With Exudative Age-Related Macular Degeneration
- (2019) Lauren A. Dalvin et al. JAMA Ophthalmology
- Classification of Strokes in Patients Receiving Intravitreal Anti-Vascular Endothelial Growth Factor
- (2019) Matthew R. Starr et al. Ophthalmic Surgery Lasers & Imaging Retina
- Eye complications of diabetes
- (2019) Giuseppe Querques ACTA DIABETOLOGICA
- Systemic thromboembolic adverse events in patients treated with intravitreal anti-VEGF drugs for neovascular age-related macular degeneration: an update
- (2019) Ciro Costagliola et al. Expert Opinion On Drug Safety
- Real-world outcomes of non-responding diabetic macular edema treated with continued anti-VEGF therapy versus early switch to dexamethasone implant: 2-year results
- (2019) Catharina Busch et al. ACTA DIABETOLOGICA
- Influence of aflibercept on platelet activation profile
- (2018) B. Sobolewska et al. EXPERIMENTAL EYE RESEARCH
- Plasma Vascular Endothelial Growth Factor Concentrations after Intravitreous Anti–Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema
- (2018) Lee M. Jampol et al. OPHTHALMOLOGY
- Bevacizumab-induced hypertension: Clinical presentation and molecular understanding
- (2018) Megan Li et al. PHARMACOLOGY & THERAPEUTICS
- Overview of Systematic Reviews and Meta-analyses on Systemic Adverse Events Associated With Intravitreal Anti–Vascular Endothelial Growth Factor Medication Use
- (2018) Marie Thulliez et al. JAMA Ophthalmology
- Risk of Systemic Adverse Events Associated with Intravitreal Anti–VEGF Therapy for Diabetic Macular Edema in Routine Clinical Practice
- (2018) Maya H. Maloney et al. OPHTHALMOLOGY
- Prediction of risk of diabetic retinopathy for all-cause mortality, stroke and heart failure
- (2017) Xiao-Rong Zhu et al. MEDICINE
- SYSTEMIC PHARMACOKINETICS AND PHARMACODYNAMICS OF INTRAVITREAL AFLIBERCEPT, BEVACIZUMAB, AND RANIBIZUMAB
- (2017) Robert L. Avery et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Mortality in patients treated with intravitreal bevacizumab for age-related macular degeneration
- (2017) Joel Hanhart et al. BMC Ophthalmology
- Vascular Safety of Ranibizumab in Patients With Diabetic Macular Edema
- (2017) Marco A. Zarbin et al. JAMA Ophthalmology
- Integration of pro- and anti-angiogenic signals by endothelial cells
- (2017) Shideh Kazerounian et al. Journal of Cell Communication and Signaling
- Increased Burden of Cerebral Small Vessel Disease in Patients With Type 2 Diabetes and Retinopathy
- (2016) Jordi Sanahuja et al. DIABETES CARE
- Intravitreal Aflibercept for Diabetic Macular Edema
- (2016) Jeffrey S. Heier et al. OPHTHALMOLOGY
- Diabetic Macular Edema Pathophysiology: Vasogenic versus Inflammatory
- (2016) Pedro Romero-Aroca et al. Journal of Diabetes Research
- Systemic Safety of Prolonged Monthly Anti–Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema
- (2016) Robert L. Avery et al. JAMA Ophthalmology
- Designed Ankyrin Repeat Proteins (DARPins): Binding Proteins for Research, Diagnostics, and Therapy
- (2015) Andreas Plückthun Annual Review of Pharmacology and Toxicology
- Pharmacokinetic and Pharmacodynamic Properties of Anti-VEGF Drugs After Intravitreal Injection
- (2015) Francesco Semeraro et al. CURRENT DRUG METABOLISM
- Myofibroblasts in proliferative diabetic retinopathy can originate from infiltrating fibrocytes and through endothelial-to-mesenchymal transition (EndoMT)
- (2015) Ahmed M. Abu El-Asrar et al. EXPERIMENTAL EYE RESEARCH
- Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy
- (2015) et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Neuropilin 1 (NRP1) hypomorphism combined with defective VEGF-A binding reveals novel roles for NRP1 in developmental and pathological angiogenesis
- (2014) A. Fantin et al. DEVELOPMENT
- Three-Year Outcomes of Individualized Ranibizumab Treatment in Patients with Diabetic Macular Edema
- (2014) Ursula Schmidt-Erfurth et al. OPHTHALMOLOGY
- Safety and Efficacy of Conbercept in Neovascular Age-Related Macular Degeneration
- (2014) Xiaoxin Li et al. OPHTHALMOLOGY
- Systemic Vascular Safety of Ranibizumab for Age-Related Macular Degeneration
- (2014) Takashi Ueta et al. OPHTHALMOLOGY
- Control of Angiogenesis by Galectins Involves the Release of Platelet-Derived Proangiogenic Factors
- (2014) Julia Etulain et al. PLoS One
- Cardiovascular Events and Bleeding Risk Associated With Intravitreal Antivascular Endothelial Growth Factor Monoclonal Antibodies
- (2014) Marie Thulliez et al. JAMA Ophthalmology
- VEGF-A165b Is an Endogenous Neuroprotective Splice Isoform of Vascular Endothelial Growth Factor A in Vivo and in Vitro
- (2013) Nicholas Beazley-Long et al. AMERICAN JOURNAL OF PATHOLOGY
- Bevacizumab vs ranibizumab—an appraisal of the evidence from CATT and IVAN
- (2013) F G Ahfat et al. EYE
- eNOS-derived nitric oxide regulates endothelial barrier function through VE-cadherin and Rho GTPases
- (2013) Annarita Di Lorenzo et al. JOURNAL OF CELL SCIENCE
- Long-term Outcomes of Ranibizumab Therapy for Diabetic Macular Edema: The 36-Month Results from Two Phase III Trials
- (2013) David M. Brown et al. OPHTHALMOLOGY
- Neurodegeneration in the diabetic eye: new insights and therapeutic perspectives
- (2013) Rafael Simó et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- A 2-Year Prospective Randomized Controlled Trial of Intravitreal Bevacizumab or Laser Therapy (BOLT) in the Management of Diabetic Macular Edema
- (2012) Ranjan Rajendram et al. ARCHIVES OF OPHTHALMOLOGY
- The vascular endothelial growth factor (VEGF)-E encoded by orf virus regulates keratinocyte proliferation and migration and promotes epidermal regeneration
- (2012) Lyn M. Wise et al. CELLULAR MICROBIOLOGY
- Effect of Intravitreal Anti-Vascular Endothelial Growth Factor Therapy on the Risk of Arterial Thromboembolic Events: A Meta-Analysis
- (2012) Jin-Wei Cheng et al. PLoS One
- Hospitalized cardiovascular events in patients with diabetic macular edema
- (2012) Bao-Anh Nguyen-Khoa et al. BMC Ophthalmology
- Plasma levels of vascular endothelial growth factor and pigment epithelium-derived factor before and after intravitreal injection of bevacizumab
- (2010) K. Matsuyama et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Snake Venom Vascular Endothelial Growth Factors (VEGF-Fs) Exclusively Vary Their Structures and Functions among Species
- (2009) Yasuo Yamazaki et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The basics of epithelial-mesenchymal transition
- (2009) Raghu Kalluri et al. JOURNAL OF CLINICAL INVESTIGATION
- Retinopathy predicts coronary heart disease mortality
- (2008) G Liew et al. HEART
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started